Dr. Antonarakis on AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer Targeted Oncology 1:20 10 years ago 438 Далее Скачать
Dr. Emmanuel S. Antonarakis on the Future of the AR-V7 Biomarker in Prostate Cancer Targeted Oncology 1:04 9 years ago 540 Далее Скачать
Dr. Antonarakis on AR-V7 and Resistance to AR-Targeting Agents in mCRPC OncLive 1:41 10 years ago 203 Далее Скачать
Dr. Antonarakis Discusses AR-V7 and Response to Taxanes in Men With mCRPC OncLive 1:32 9 years ago 388 Далее Скачать
Dr. Dreicer on Resistance to Antiandrogen Therapy in Prostate Cancer OncLive 1:09 8 years ago 269 Далее Скачать
Dr. Dreicer on Abiraterone and Enzalutamide in Prostate Cancer OncLive 1:14 7 years ago 507 Далее Скачать
Antonarakis: AR-V7, Taxane Response in mCRPC Cancer Therapy Advisor 1:12 9 years ago 118 Далее Скачать
AR-V7 in Castration Resistant Prostate Cancer Grand Rounds in Urology 29:02 6 years ago 624 Далее Скачать
Dr. Antonarakis on Implications of an MMR Deficiency in Prostate Cancer OncLive 1:22 5 years ago 151 Далее Скачать
Dr. Pal on Sequencing Abiraterone and Enzalutamide in mCRPC Targeted Oncology 1:12 10 years ago 240 Далее Скачать
The Value of AR-V7 for Prostate Cancer Patients Prostate Conditions Education Council 33:38 5 years ago 241 Далее Скачать
